ACTINIUM PHARMACEUTICALS INC - COM (ATNM)

CUSIP: 00507W107

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
2,715,128
Share change
+6,307
Total reported value
$15,972,590
Price per share
$5.89
Number of holders
36
Value change
-$210,302
Number of buys
21
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 00507W107?
CUSIP 00507W107 identifies ATNM - ACTINIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) as of Q4 2014

As of 31 Dec 2014, ACTINIUM PHARMACEUTICALS INC - COM (ATNM) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,715,128 shares. The largest 10 holders included BlackRock Fund Advisors, VANGUARD GROUP INC, State Street Corp, NORTHERN TRUST CORP, BlackRock Institutional Trust Company, N.A., GEODE CAPITAL MANAGEMENT, LLC, TIAA CREF INVESTMENT MANAGEMENT LLC, KCG Holdings, Inc., Bank of New York Mellon Corp, and TFS CAPITAL LLC. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.